Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+43.4%
5Y CAGR+124.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+43.4%/yr
Annual compound
5Y CAGR
+124.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
57.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.21 | +104.2% |
| 2024 | 0.59 | -23.4% |
| 2023 | 0.77 | +88.3% |
| 2022 | 0.41 | +82.3% |
| 2021 | 0.23 | +965.8% |
| 2020 | 0.02 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |